HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Scilimati Selected Research

Neuroendocrine Tumors (Neuroendocrine Tumor)

2/2020Impact of 68Ga-DOTATOC PET/CT in comparison to 111In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report.
3/2017A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
3/2017Pharmaceutical development of novel lactate-based 6-fluoro-l-DOPA formulations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Scilimati Research Topics

Disease

6Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 03/2014
5Neoplasms (Cancer)
05/2022 - 01/2008
5Neuroinflammatory Diseases
12/2017 - 01/2012
3Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2020 - 03/2017
3Pain (Aches)
02/2019 - 01/2015
2Inflammation (Inflammations)
11/2020 - 01/2017
2Parkinson Disease (Parkinson's Disease)
03/2017 - 03/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 03/2006
2Heart Failure
01/2010 - 02/2005
2Colonic Neoplasms (Colon Cancer)
01/2010 - 01/2008
1Frailty
01/2022
1Bone Diseases (Bone Disease)
01/2022
1Bone Resorption
01/2022
1Bone Fractures (Bone Fracture)
01/2022
1Cantu syndrome
01/2022
1Drug-Related Side Effects and Adverse Reactions
08/2021
1Diffuse Intrinsic Pontine Glioma
01/2021
1Mental Disorders (Mental Disorder)
11/2020
1Ischemic Stroke
10/2020
1Stroke (Strokes)
10/2020
1Hemolysis
02/2019
1Multiple Myeloma
02/2019
1Plasma Cell Neoplasms
02/2019
1Osteoporosis
10/2018
1Neuroblastoma
03/2017
1Glioma (Gliomas)
03/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017
1Carcinogenesis
01/2015
1Ovarian Epithelial Carcinoma
06/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012
1Type 2 Diabetes Mellitus (MODY)
01/2010
1Obesity
01/2010
1Cachexia
01/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010
1Depressive Disorder (Melancholia)
01/2010
1Overactive Urinary Bladder (Overactive Bladder)
01/2010
1Premature Obstetric Labor (Premature Labor)
01/2010
1Neoplasm Metastasis (Metastasis)
01/2008
1Atherosclerosis
02/2005
1Dyslipidemias (Dyslipidemia)
02/2005
1Dehydration (Water Stress)
09/2004

Drug/Important Bio-Agent (IBA)

5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2022 - 01/2017
5mofezolacIBA
10/2020 - 01/2017
4Cyclooxygenase 1IBA
10/2020 - 06/2014
3Biomarkers (Surrogate Marker)IBA
05/2022 - 06/2014
3Pharmaceutical PreparationsIBA
01/2022 - 01/2010
3Diphosphonates (Bisphosphonates)IBA
01/2022 - 10/2018
2Fluorescent Dyes (Fluorescent Probes)IBA
05/2022 - 10/2019
2Dihydroxyphenylalanine (Dopa)IBA
03/2017 - 03/2017
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2012 - 03/2006
2Messenger RNA (mRNA)IBA
01/2012 - 01/2008
1Protein Isoforms (Isoforms)IBA
05/2022
1farnesyl pyrophosphate (farnesyl diphosphate)IBA
01/2022
1Zoledronic Acid (Zometa)FDA Link
08/2021
1Adenosine Triphosphate (ATP)IBA
08/2021
1Dopamine AntagonistsIBA
01/2021
1dipinacoline glutamateIBA
01/2021
1TIC10 compoundIBA
01/2021
1Radioisotopes (Radionuclides)IBA
02/2020
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2020
1indium-111-octreotideIBA
02/2020
1Ga(III)-DOTATOCIBA
02/2020
1Peptide Receptors (Peptide Receptor)IBA
02/2020
1Proteasome InhibitorsIBA
02/2019
1Proteins (Proteins, Gene)FDA Link
02/2019
1MutagensIBA
02/2019
1Bortezomib (Velcade)FDA Link
02/2019
1LigandsIBA
02/2019
1AcidsIBA
10/2018
1Dinoprostone (PGE2)FDA Link
12/2017
1CyclodextrinsIBA
03/2017
1Dosage Forms (Dosage Form)IBA
03/2017
1Levodopa (L Dopa)FDA LinkGeneric
03/2017
1Glial Fibrillary Acidic ProteinIBA
01/2017
1NF-kappa B (NF-kB)IBA
01/2017
1CalciumIBA
01/2017
1S-Adenosylmethionine (Ademetionine)IBA
01/2017
1LipopolysaccharidesIBA
01/2017
1Neuroprotective AgentsIBA
01/2017
1Plant ExtractsIBA
01/2016
1EnzymesIBA
03/2014
1EtoricoxibIBA
01/2012
1Prostaglandins EIBA
01/2012
1Celecoxib (Celebrex)FDA Link
01/2012
1SC 560IBA
01/2012
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2012
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2008
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2008
1PPAR alphaIBA
02/2005
1Fibric Acids (Fibrates)IBA
02/2005
1BenzenesulfonamidesIBA
09/2004

Therapy/Procedure

5Therapeutics
01/2022 - 01/2010
1Drug Therapy (Chemotherapy)
01/2020
1Injections
03/2017
1Precision Medicine
01/2016